Sponsor or institution

Clinical trials and research at West China Second University Hospital

• 6Clinical trials
• 1Country

Newest trials

All recruiting trials (6)

• Modified LCH-III chemotherapy with or without luvometinib for multisystem pediatric LCH

  This trial will test whether adding luvometinib to a modified LCH-III chemotherapy plan helps children (ages 0–18) with multisystem Langerhans cell histiocytosis stay in remission longer.

  Recruiting at 11 sites West China Second University Hospital · Chengdu and 10 other locations · NCT07431060

• Luvometinib for children with single-system multifocal or special-site bone LCH

  This project tests whether the drug luvometinib can help children with Langerhans cell histiocytosis that affects certain bones or has multiple bone lesions.

  Recruiting at 11 sites West China Second University Hospital · Hefei, Anhui and 10 other locations · NCT07371182

• Dabrafenib or Trametinib plus Clofarabine for high-risk or relapsed pediatric Langerhans cell histiocytosis

  This treatment will test whether adding a MAPK inhibitor (dabrafenib or trametinib) to the chemotherapy drug clofarabine helps children and teens (0–18) with high-risk, recurrent, or refractory Langerhans cell histiocytosis.

  Recruiting Phase 2 West China Second University Hospital · Chengdu, Sichuan · NCT07022834

• Aerosolized Peginterferon α-2b for treating RSV pneumonia in young children

  This study is testing if a new inhaled treatment can help young children with RSV pneumonia feel better.

  Recruiting at 2 sites West China Second University Hospital · Chengdu, Sichuan and 1 other locations · NCT06881056

• Monitoring heart health in patients receiving immune checkpoint inhibitors for gynecologic cancers

  This study is looking at how immune checkpoint inhibitors affect heart health in women with gynecologic cancers by checking their heart function before and after treatment.

  Recruiting West China Second University Hospital · Chengdu, Sichuan · NCT06132984

• Using a hormonal device to preserve fertility in patients with early endometrial cancer and atypical hyperplasia

  This study is testing if a hormonal device can help women under 40 with early endometrial cancer and atypical hyperplasia keep their fertility while monitoring their health and pregnancy outcomes.

  Recruiting Phase 2/3 West China Second University Hospital · Chengdu, Sichuan · NCT03463252

Quick answers

How many clinical trials run by West China Second University Hospital are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →